Order Article Reprints

Sampei Z, Koo CX, Teo FJ, Toh YX, Fukuzawa T, Gan SW, Nambu T, Ho A, Honda K, Igawa T, et al. Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement. Antibodies. 2023; 12(2):36. https://doi.org/10.3390/antib12020036

Sampei, Zenjiro, Christine Xing’er Koo, Frannie Jiuyi Teo, Ying Xiu Toh, Taku Fukuzawa, Siok Wan Gan, Takeru Nambu, Adrian Ho, Kiyofumi Honda, Tomoyuki Igawa, and et al. 2023. "Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement" Antibodies 12, no. 2: 36. https://doi.org/10.3390/antib12020036

Sampei, Z., Koo, C. X., Teo, F. J., Toh, Y. X., Fukuzawa, T., Gan, S. W., Nambu, T., Ho, A., Honda, K., Igawa, T., Ahmed, F., Wang, C.-I., Fink, K., & Nezu, J. (2023). Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement. Antibodies, 12(2), 36. https://doi.org/10.3390/antib12020036